JP2007518724A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518724A5
JP2007518724A5 JP2006547586A JP2006547586A JP2007518724A5 JP 2007518724 A5 JP2007518724 A5 JP 2007518724A5 JP 2006547586 A JP2006547586 A JP 2006547586A JP 2006547586 A JP2006547586 A JP 2006547586A JP 2007518724 A5 JP2007518724 A5 JP 2007518724A5
Authority
JP
Japan
Prior art keywords
gly
pharmaceutical composition
asp
glu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006547586A
Other languages
English (en)
Japanese (ja)
Other versions
JP5044829B2 (ja
JP2007518724A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/044012 external-priority patent/WO2005065706A1/en
Publication of JP2007518724A publication Critical patent/JP2007518724A/ja
Publication of JP2007518724A5 publication Critical patent/JP2007518724A5/ja
Application granted granted Critical
Publication of JP5044829B2 publication Critical patent/JP5044829B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006547586A 2003-12-31 2004-12-30 トロンビンペプチド誘導体のための医薬組成物 Expired - Lifetime JP5044829B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53373003P 2003-12-31 2003-12-31
US60/533,730 2003-12-31
PCT/US2004/044012 WO2005065706A1 (en) 2003-12-31 2004-12-30 Pharmaceutical composition for thrombin peptide derivatives

Publications (3)

Publication Number Publication Date
JP2007518724A JP2007518724A (ja) 2007-07-12
JP2007518724A5 true JP2007518724A5 (enExample) 2008-01-31
JP5044829B2 JP5044829B2 (ja) 2012-10-10

Family

ID=34652502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006547586A Expired - Lifetime JP5044829B2 (ja) 2003-12-31 2004-12-30 トロンビンペプチド誘導体のための医薬組成物

Country Status (13)

Country Link
US (2) US7291596B2 (enExample)
EP (1) EP1559431B1 (enExample)
JP (1) JP5044829B2 (enExample)
CN (1) CN1913917B (enExample)
AT (1) ATE357928T1 (enExample)
AU (1) AU2004312090B2 (enExample)
CA (1) CA2551525C (enExample)
DE (1) DE602004005564T2 (enExample)
DK (1) DK1559431T3 (enExample)
ES (1) ES2287660T3 (enExample)
PL (1) PL1559431T3 (enExample)
PT (1) PT1559431E (enExample)
WO (1) WO2005065706A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2491135A1 (en) * 2002-07-02 2004-01-15 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
CN101563102B (zh) * 2006-09-22 2014-12-17 德克萨斯系统大学董事会 治疗内皮功能障碍的方法
US8227412B2 (en) * 2007-03-29 2012-07-24 Tsopanoglou Nikos E Bioactive parstatin peptides and methods of use
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
AU2009229395A1 (en) * 2008-03-26 2009-10-01 The Board Of Regents, The University Of Texas System Method of treating degenerative diseases
CA2722620A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
AU2009229399A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
US20110319340A1 (en) * 2008-09-19 2011-12-29 The Board Of Regents, The University Of Texas System Methods for treating cancer
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
JP6025256B2 (ja) 2010-02-23 2016-11-16 コーニング インコーポレイテッド ペプチド固定化表面をγ線劣化から保護するための修飾基板
JP6529438B2 (ja) 2012-11-29 2019-06-12 インスメッド インコーポレイテッド 安定化されたバンコマイシン処方物
CN105579048B (zh) * 2013-10-03 2024-11-26 L·A·艾姆斯蒂卡萨拉查 包括一种或多种选自mf、uf、pf、muf和酚类树脂的树脂以及一种以上的可溶性铜盐的树脂杀生物剂组合物
ES2926985T3 (es) 2014-05-15 2022-10-31 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CN105879010A (zh) * 2015-01-17 2016-08-24 内蒙古天奇生物科技有限公司 一种能促进创伤愈合减轻创后瘢痕的多肽组合物及其制备方法
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
WO2020210087A1 (en) * 2019-04-12 2020-10-15 Affirmed Pharma, Llc Rusalatide acetate compositions
JP2023139750A (ja) * 2022-03-22 2023-10-04 株式会社東芝 抗酸化剤を用いたｆｅｔセンサ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019612A1 (de) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisiertes thrombinpraeparat
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
JP2000229882A (ja) * 1998-12-10 2000-08-22 Sankyo Co Ltd 修飾シクロデキストリン含有トロンビン水性液剤
GB9930768D0 (en) 1999-12-29 2000-02-16 Pfizer Ltd Composition
TWI257307B (en) * 2000-07-12 2006-07-01 Orthologic Corp Pharmaceutical composition for cardiac tissue repair
EP1301196B1 (en) 2000-07-19 2003-11-26 The Board of Regents, The University of Texas System Stimulation of bone growth with thrombin peptide derivatives
CN1458974A (zh) * 2000-07-20 2003-11-26 德克萨斯系统大学董事会 用非蛋白质水解激活的凝血酶受体的激动剂刺激软骨生长
MXPA03003482A (es) * 2000-11-17 2004-09-10 Warner Lambert Co Tratamiento de disfuncion sexual.
MXPA03007619A (es) * 2001-02-27 2003-12-04 Maxygen Aps Nuevas moleculas similares a interferon beta.
JP4192093B2 (ja) 2001-07-27 2008-12-03 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 慢性皮膚潰瘍の治癒を促進する方法
EP1467749B1 (en) 2002-01-16 2011-04-06 Capstone Therapeutics Corp. Thrombin derived peptides for promoting cardiac tissue repair
EP1467748A1 (en) 2002-01-17 2004-10-20 Board Of Regents The University Of Texas System Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
ES2377959T3 (es) * 2002-05-03 2012-04-03 Novo Nordisk Health Care Ag Composiciones sólidas estabilizadas de factor VII modificado
CA2491135A1 (en) * 2002-07-02 2004-01-15 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
WO2004014937A2 (en) * 2002-07-02 2004-02-19 The Board Of Regents, The University Of Texas System Thrombin peptide derivatives

Similar Documents

Publication Publication Date Title
JP2007518724A5 (enExample)
US11786491B2 (en) Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
Veber et al. The design of metabolically-stable peptide analogs
US20230190683A1 (en) Methods for the treatment of cysteamine sensitive disorders
JP6223377B2 (ja) 長期間作用性ペプチド類似体のための組成物
AU2004259028C1 (en) Stable radiopharmaceutical compositions and methods for preparation
US7875588B2 (en) Methods of therapy using pharmaceutical composition for thrombin peptide derivatives
JPH08508259A (ja) 血栓症の阻害剤としてのα−ケトアミド誘導体
PT736039E (pt) Compostos com propriedades para liberar a hormona de crescimento
BRPI0717135B1 (pt) Antagonista peptídico cíclico de somastotatina e composição farmacêutica
JP2004521123A5 (enExample)
EP0667163B1 (en) Powder for nasal administration of peptidic or proteinaceous drug
JPWO1995003818A1 (ja) ペプチド，蛋白質性薬物経鼻粉剤
JP2017501967A (ja) 新規なペプチド組成物
AR037943A1 (es) Derivados de pirimidinilsulfonamida, el uso de dichos compuestos solo o en combinacion para la produccion de medicamentos y un proceso para la manufactura de composiciones farmaceuticas
RS51029B (sr) Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartroze
MXPA06000918A (es) Composiciones radiofarmaceuticas estables y metodos para su preparacion
JPH1072363A (ja) 脳梗塞疾患の予防治療剤